Intraoperative monitoring of laboratory parameters of age-related diseases, by using information systems during the novel coronavirus infection

DOI: https://doi.org/10.29296/25877305-2022-06-13
Issue: 
6
Year: 
2022

N. Zhukova(1), Associate Professor S. Rukavishnikova(1), Biol.D; U. Saginbaev(1), Candidate of Biological Sciences; Associate Professor T. Akhmedov(1), Candidate of Medical Sciences; Associate Professor A. Pushkin(1), Biol.D; S. Lenkin(2), Candidate of Medical Sciences
1-Saint Petersburg Institute of Bioregulation and Gerontology
2-Medical center «Paid KVD», Moscow

The quarantine measures introduced as a result of the novel coronavirus infection (NCI) pandemic have contributed to the implementation of modern opportunities for remote work, remote transmission of data and laboratory study results. An electronic laboratory research data exchange (LRDE) system has been created in Saint Petersburg. Objective: based on a literature review, to describe the possibilities of using information systems to improve the quality of health care for patients with age-related diseases during the COVID-19 pandemic. Material and methods. Scientific literature, regulatory legal acts, drug instructions were used as the material of the study. Results and discussion. The need for remote health information in a new reality has identified a new challenge for remote access and further improvement of high-tech software systems. The transfer of data to the LRDE system meets all cybersecurity and timeliness criteria. Continuous remote work and transmission of results during peak periods prevents the spread of NCI. The post-analysis of this situation emphasizes the critical priority of introducing a new level of computer literacy, primarily among healthcare workers. Computer programs in clinical laboratory diagnosis are widely used not only for data transfer, i.e. they perform a communicative function, but also to receive, convert, and estimate various parameters. Conclusion. The development and implementation of new information systems can reduce the incidence of age-related diseases and NCI, as well as significantly improve quality of life in elderly and senile patients
Keywords: 
geriatrics
information system
age-related disease
COVID-19
software

References: 
  1. Bassetti M. The Novel Chinese Coronavirus (2019-nCoV) Infections: challenges for fighting the storm. Eur J Clin Invest. 2020; 50 (3): 13209. DOI: 10.1111/eci.13209
  2. Shamsheva O.V. New Coronavirus COVID-19 (SARS-CoV-2). Children Infections. 2020; 19 (1): 5–6 (in Russ.). DOI: 10.22627/2072-8107-2020-19-1-5-6
  3. Hussin A.R., Sidappa N.B. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109: 44–8. DOI: 10.1016/j.jaut.2020.102433
  4. Lvov D.K., Kolobukhina L.V., Deryabin P.G. Coronavirus infection. Severe acute respiratory syndrom. Infektsionnye bolezni: Novosti. Mneniya. Obuchenie. 2015; 4: 35–42 (in Russ.).
  5. Arkhipkin A.A., Nazirov M.R., Lyang O.V. et al. The special assessment of working conditions in medical laboratories. Laboratory Service. 2015; 4 (1): 42–8 (in Russ.). DOI: 10.17116/labs20154142-48
  6. Grashchenkov D.V., Chugunova O.V. Development of an electronic database of technological documents for catering in preschool institutions. Collection of articles of the III International Scientific and Practical Conference. 2015; р. 28–32 (in Russ.).
  7. Kishkun A.A. Clinical laboratory diagnostics. M.: GEOTAR-Media, 2008; 720 р. (in Russ.).
  8. Order of the Health Committee of St. Petersburg No.140-р of 26.03.2020 «On measures for the additional deployment of pulmonological beds in St. Petersburg in the 2020 season» (in Russ.).
  9. Bakaeva S., Tsurcumia D., Seliverstov P. et al. The place of telemedicine in modern healthcare. Meditsinskaya sestra. 2022; 24 (2): 30–4 (in Russ.). DOI: 10.29296/25879979-2022-02-08
  10. Federal Law No. 44-ФЗ dated 05.04 2013 «On the contract system in the field of procurement of goods, works, services to meet state and municipal needs» (in Russ.).
  11. Borodulina E.A., Shirobokov Y.E., Gladunova E.P. et al. Virus-associated lung disease. Klinicheskaya farmakologiya i terapiya = Clin Pharmacol Ther. 2020; 29 (3): 61–6 (in Russ.). DOI: 10.32756/0869-5490-2020-3-61-66
  12. Borodulina E.A., Vasneva Z.P., Vdoushkina E.S. et al. Features of Hematological and Hemostasiological Parameters in Coronavirus Infection COVID-19 and Community-Acquired Pneumonia. Acta Biomedica Scientifica. 2021; 6 (1): 40–7 (in Russ.). DOI: 10.29413/ABS.2021-6.1.6
  13. Bissenova N.M., Yergaliyeva A.S. Microbiological indicators of patients with confirmed infection COVID-19. Nauka i Zdravookhranenie = Science & Healthcare. 2020; 6 (22): 5–10 (in Russ.). DOI: 10.34689/SH.2020.22.6.001
  14. Tkacheva O.N., Kotovskaya Yu.V., Aleksanyan L.A. et al. Novel coronavirus infection SARS-CoV-2 in elderly and senile patients: prevention, diagnosis and treatment. Expert Position Paper of the Russian Association of Gerontology and Geriatrics. Cardiovascular Therapy and Prevention. 2020; 19 (3): 2601 (in Russ.). DOI: 10.15829/1728-8800-2020-2601
  15. Kudlay D., Shirobokov Ya., Gladunova E. et al. Diagnosis of COVID-19. Methods and problems of virus SARS-CoV-2 detection under pandemic conditions. Vrach. 2020; 31 (8): 5–10 (in Russ.). DOI: 10.29296/25877305-2020-08-01
  16. Puzin S.N., Shurgaya M.A., Odebaeva R.O. Disability of elderly people due to hypertensive disease in the Russian Federation. Uspekhi gerontologii. 2018; 1 (31): 32–8 (in Russ.).
  17. Kamyshnikov V.S. Clinical Laboratory Methods. M.: MED press-inform, 2016; 736 р. (in Russ.).
  18. Alekseev V.V. Medical laboratory technology. a clinical laboratory diagnostic guideline in 2 volumes. M.: GEOTAR-Media, 2013; 792 р. (in Russ.).
  19. Kishkun A.A. Laboratory Diagnostic Manual. M.: GEOTAR-Media, 2014; 760 р. (in Russ.).
  20. Wallach J. Interpretation of diagnostic tests. M: EKSMO, 2013; 1358 р. (in Russ.).
  21. Dedov D.V., Marchenko S.D. Vitamins, iron, zinc, selenium, selenium-containing drugs in the complex prevention of complications and treatment of patients with COVID-19. Pharmacy. 2022; 71 (1): 5–9 (in Russ.). DOI: 10.29296/25419218-2022-01-01